Use of glutamine synthetase for treating fatty liver disease
US12414986B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 28, 2019 |
| Grant date | Sep 16, 2025 |
| Priority date | — |
| Expiry date | Aug 17, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/21
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the treatment of fatty liver disease, by administration of glutamine synthetase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.